Terracciano Rossana, Zhang Aobo, Butler E Brian, Demarchi Danilo, Hafner Jason H, Grattoni Alessandro, Filgueira Carly S
Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030, USA.
Department of Electronics, Politecnico di Torino, 10129 Torino, Italy.
Pharmaceutics. 2021 Feb 5;13(2):216. doi: 10.3390/pharmaceutics13020216.
The heterogeneous distribution of delivery or treatment modalities within the tumor mass is a crucial limiting factor for a vast range of theranostic applications. Understanding the interactions between a nanomaterial and the tumor microenvironment will help to overcome challenges associated with tumor heterogeneity, as well as the clinical translation of nanotheranostic materials. This study aims to evaluate the influence of protein surface adsorption on gold nanoparticle (GNP) biodistribution using high-resolution computed tomography (CT) preclinical imaging in C57BL/6 mice harboring Lewis lung carcinoma (LLC) tumors. LLC provides a valuable model for study due to its highly heterogenous nature, which makes drug delivery to the tumor challenging. By controlling the adsorption of proteins on the GNP surface, we hypothesize that we can influence the intratumoral distribution pattern and particle retention. We performed an in vitro study to evaluate the uptake of GNPs by LLC cells and an in vivo study to assess and quantify the GNP biodistribution by injecting concentrated GNPs citrate-stabilized or passivated with bovine serum albumin (BSA) intratumorally into LLC solid tumors. Quantitative CT and inductively coupled plasma optical emission spectrometry (ICP-OES) results both confirm the presence of particles in the tumor 9 days post-injection ( = 8 mice/group). A significant difference is highlighted between citrate-GNP and BSA-GNP groups (** < 0.005, Tukey's multiple comparisons test), confirming that the protein corona of GNPs modifies intratumoral distribution and retention of the particles. In conclusion, our investigations show that the surface passivation of GNPs influences the mechanism of cellular uptake and intratumoral distribution in vivo, highlighting the spatial heterogeneity of the solid tumor.
肿瘤块内递送或治疗方式的异质分布是众多诊疗应用的关键限制因素。了解纳米材料与肿瘤微环境之间的相互作用将有助于克服与肿瘤异质性相关的挑战,以及纳米诊疗材料的临床转化。本研究旨在利用高分辨率计算机断层扫描(CT)临床前成像技术,评估蛋白质表面吸附对携带Lewis肺癌(LLC)肿瘤的C57BL/6小鼠体内金纳米颗粒(GNP)生物分布的影响。由于LLC具有高度异质性,使其成为一个有价值的研究模型,药物递送至该肿瘤具有挑战性。通过控制蛋白质在GNP表面的吸附,我们假设可以影响肿瘤内分布模式和颗粒滞留。我们进行了一项体外研究,以评估LLC细胞对GNPs的摄取,并进行了一项体内研究,通过将浓缩的柠檬酸稳定化或用牛血清白蛋白(BSA)钝化的GNPs瘤内注射到LLC实体瘤中,来评估和量化GNP的生物分布。定量CT和电感耦合等离子体发射光谱(ICP-OES)结果均证实注射后9天肿瘤内存在颗粒(每组n = 8只小鼠)。柠檬酸-GNP组和BSA-GNP组之间存在显著差异(**P < 0.005,Tukey多重比较检验),证实了GNPs的蛋白质冠层改变了颗粒在肿瘤内的分布和滞留。总之,我们的研究表明,GNPs的表面钝化会影响体内细胞摄取机制和肿瘤内分布,突出了实体瘤的空间异质性。